MedTrace Logo

The EFFect of hIgh Dose ClopIdogrel treatmENT in Patients With Clopidogrel Resistance

NCT01032668 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2009-12-15

No results posted yet for this study

Summary

Continuing high dose clopidogrel treatment after elective PCI decreased adverse cardiac events in patients with clopidogrel resistance

Conditions

Interventions

DRUG

Clopidogrel

high dose clopidogrel continuing after percutaneous coronary intervention

Sponsors & Collaborators

  • Bursa Postgraduate Hospital

    lead OTHER

Principal Investigators

  • Hasan ARI, MD · Bursa Postgraduate Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-07-31
Completion
2009-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01032668 on ClinicalTrials.gov